JP2023551467A5 - - Google Patents
Info
- Publication number
- JP2023551467A5 JP2023551467A5 JP2023532125A JP2023532125A JP2023551467A5 JP 2023551467 A5 JP2023551467 A5 JP 2023551467A5 JP 2023532125 A JP2023532125 A JP 2023532125A JP 2023532125 A JP2023532125 A JP 2023532125A JP 2023551467 A5 JP2023551467 A5 JP 2023551467A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formulated
- use according
- condition
- phenylacetyluridine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063119764P | 2020-12-01 | 2020-12-01 | |
| US63/119,764 | 2020-12-01 | ||
| PCT/US2021/061053 WO2022119784A1 (en) | 2020-12-01 | 2021-11-30 | 5'-o-phenylacetyluridine and therapeutic use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023551467A JP2023551467A (ja) | 2023-12-08 |
| JP2023551467A5 true JP2023551467A5 (https=) | 2024-12-06 |
Family
ID=81854225
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023532125A Pending JP2023551467A (ja) | 2020-12-01 | 2021-11-30 | ５’－ｏ－フェニルアセチルウリジン及び治療上の使用 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20230416292A1 (https=) |
| EP (2) | EP4255563B1 (https=) |
| JP (1) | JP2023551467A (https=) |
| KR (1) | KR20230112118A (https=) |
| CN (1) | CN116782912A (https=) |
| AU (1) | AU2021391411A1 (https=) |
| BR (1) | BR112023010517A2 (https=) |
| CA (1) | CA3199559A1 (https=) |
| DK (1) | DK4255563T3 (https=) |
| FI (1) | FI4255563T3 (https=) |
| IL (1) | IL303100A (https=) |
| LT (1) | LT4255563T (https=) |
| MX (1) | MX2023006343A (https=) |
| PL (1) | PL4255563T3 (https=) |
| PT (1) | PT4255563T (https=) |
| WO (1) | WO2022119784A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT4210709T (pt) | 2020-09-14 | 2026-02-04 | Pharma Cinq Llc | 2¿,3¿‐diacetiluridina substituída com acetoacetilo na posição 5¿ |
| TW202317144A (zh) * | 2021-06-14 | 2023-05-01 | 美商維納拓爾斯製藥公司 | 口服生物可利用的核苷類似物 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0346108A3 (en) * | 1988-06-09 | 1991-04-24 | The Wellcome Foundation Limited | Anti-infective nucleosides |
| JP2526414B2 (ja) | 1994-05-20 | 1996-08-21 | 工業技術院長 | 制ガン剤エステル化合物及びその製造方法 |
| JP4408450B2 (ja) * | 1994-07-01 | 2010-02-03 | ウェルスタット セラピューティクス コーポレイション | 全身性炎症および炎症性肝炎の処置のためのピリミジンヌクレオチド前駆体 |
| EP1808177B1 (en) * | 1999-02-23 | 2018-08-08 | The Regents of The University of California | Methods of treatment of mitochondrial disorders |
| SI2153870T1 (sl) * | 2004-11-26 | 2014-05-30 | Ucl Business Plc | Sestavki, ki obsegajo ornitin in fenilacetat ali fenilbutirat, za zdravljenje hepatitične encefalopatije |
| GB0426141D0 (en) * | 2004-11-26 | 2004-12-29 | Ucl Biomedica Plc | Treatment |
| PT2922576T (pt) * | 2012-11-21 | 2018-01-24 | Horizon Therapeutics Llc | Métodos de administração e avaliação de fármacos sequestradores de azoto para o tratamento de encefalopatia hepática |
| PL3182980T3 (pl) * | 2014-08-19 | 2021-04-19 | Wellstat Therapeutics Corporation | Leczenie chorób niedoboru glikozylacji |
| AU2019215105B2 (en) * | 2018-02-01 | 2024-12-19 | Pharma Cinq, Llc | Compositions and devices for systemic delivery of uridine |
| WO2022089612A1 (zh) * | 2020-10-30 | 2022-05-05 | 上海岸阔医药科技有限公司 | 尿苷衍生物在制备药物中的应用 |
-
2021
- 2021-11-30 US US18/036,744 patent/US20230416292A1/en active Pending
- 2021-11-30 BR BR112023010517A patent/BR112023010517A2/pt unknown
- 2021-11-30 EP EP21901291.1A patent/EP4255563B1/en active Active
- 2021-11-30 WO PCT/US2021/061053 patent/WO2022119784A1/en not_active Ceased
- 2021-11-30 KR KR1020237017758A patent/KR20230112118A/ko active Pending
- 2021-11-30 AU AU2021391411A patent/AU2021391411A1/en active Pending
- 2021-11-30 PL PL21901291.1T patent/PL4255563T3/pl unknown
- 2021-11-30 CA CA3199559A patent/CA3199559A1/en active Pending
- 2021-11-30 MX MX2023006343A patent/MX2023006343A/es unknown
- 2021-11-30 LT LTEPPCT/US2021/061053T patent/LT4255563T/lt unknown
- 2021-11-30 FI FIEP21901291.1T patent/FI4255563T3/fi active
- 2021-11-30 PT PT219012911T patent/PT4255563T/pt unknown
- 2021-11-30 EP EP25219839.5A patent/EP4711007A3/en active Pending
- 2021-11-30 DK DK21901291.1T patent/DK4255563T3/da active
- 2021-11-30 IL IL303100A patent/IL303100A/en unknown
- 2021-11-30 JP JP2023532125A patent/JP2023551467A/ja active Pending
- 2021-11-30 CN CN202180080169.0A patent/CN116782912A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL297410A (en) | Antiviral use of a nucleoside analog or a combination preparation containing a nucleoside analog | |
| CN100358872C (zh) | 吡啶酮衍生物及其应用 | |
| ES2424634T3 (es) | Forma de dosificación oral que comprende un inhibidor de PDE 4 en calidad de un ingrediente activo y polivinilpirrolidona en calidad de excipiente | |
| JP2023551467A5 (https=) | ||
| JP2008535867A5 (https=) | ||
| JP2006523216A5 (https=) | ||
| JPH06501941A (ja) | アリールピリダジノン | |
| BR112016010576B1 (pt) | Métodos de preparação de inibidores de replicação do vírus da gripe | |
| CN105311029A (zh) | 抗肿瘤活性的喹啉衍生物 | |
| CN107072968A (zh) | 环苯扎林盐酸盐的低共熔混合物配制剂 | |
| JP2009534373A5 (https=) | ||
| WO2020177744A1 (zh) | 水杨酸类小檗碱型生物碱季铵盐及其制备药物的用途 | |
| JP2010505865A5 (https=) | ||
| US8765691B2 (en) | Osmolytes for the treatment of allergic or viral respiratory diseases | |
| JP2016147914A (ja) | 上気道の疾患およびインフルエンザ症候群を治療するための組成物 | |
| CA2991156A1 (en) | Compositions and methods for the treatment of viral infection | |
| CN116236490A (zh) | 脱氧胆酸的用途及药物 | |
| WO2019237995A1 (zh) | 同时减少出血和微血管阻塞风险的药物 | |
| CN104968340A (zh) | 治疗肝脏疾病或病状的用途和方法 | |
| AU2019254962C1 (en) | Isoindole derivatives | |
| CN110613713B (zh) | 3-羟基氨基苯甲酸与索拉非尼联合用药治疗肿瘤 | |
| JPS6061527A (ja) | 抗不整脈効力を有する医薬組成物 | |
| JPH01503456A (ja) | ６‐（６‐アルキルピリドン）‐カルボスチリル化合物およびそれらの強心薬用法 | |
| JPH1112171A (ja) | 消化器疾患治療薬 | |
| JP2019502760A (ja) | 藻類プロテオグリカン抽出物含有組成物及びその使用 |